Search Courses

Radiopharmaceutical Treatments in Radiation Oncology

Course Details

MDCB Credits: 1.00

ARRT Credits: 1.00

Available Until: 1/31/2023

Non-Member Price: $35.00

Member Price: $20.00

Member PLUS Price: $20.00

Add to My Courses

Once you have exceeded your annual free credit allowance you will be prompted to pay a per-credit fee.

Courses purchased using your credit allowance are non-refundable and need to be completed before their expiration date

View your annual credit allowance here.

Presented by Murali Nair PhD, DABR
Chief Medical Physicist/RSO
Joe Arrington Cancer Center 
Covenant  Health System

This presentation will describe radiopharmaceuticals I-131, Lu-177, and Ra-223 used for the treatment of specific tumors. Physical properties, dosimetry, biodistribution, and radiation safety precautions will be outlined. Patient evaluation procedures, imaging requirements and patient instructions will also be discussed.

Learner Outcomes:

  1. Explain the importance of radiopharmaceutical therapy
  2. Discuss physical properties, radiation dosimetry and biodistribution of pharmaceuticals
  3. Outline radiation safety precautions associated with handling of radiopharmaceuticals

Educational Level: Advance

Murali Nair PhD, DABR, Chief Medical Physicist/RSO, received a PhD in Nuclear Engineering from the University of Missouri, Columbia 1985. He is also certified by the American Board of Radiology in Therapeutic, Diagnostic Radiology, and Nuclear Medicine. Dr. Nair is licensed in all three branches by the Texas Medical Board. Dr. Nair has worked as a Medical Physicist and Radiation Safety Officer in Radiation Oncology for over 30 years. He has a specialty in Stereotactic Radiosurgery using Linac and Gamma Knife. Dr. Nair also does LDR, HDR, interstitial, intracavitary brachytherapy, and radiopharmaceutical therapy.